Literature DB >> 26421066

Long-Term Results of Treatment for Critical Limb Ischemia.

Takuya Miyahara1, Masamitsu Suhara1, Yoko Nemoto1, Takuro Shirasu1, Makoto Haga1, Yasuaki Mochizuki1, Mitsuru Matsukura1, Takafumi Akai1, Ryosuke Taniguchi1, Masaru Nemoto1, Satoshi Yamamoto1, Ayako Nishiyama1, Akihiro Hosaka1, Katsuyuki Hoshina1, Hiroyuki Okamoto1, Kunihiro Shigematsu1, Tetsuro Miyata2, Toshiaki Watanabe3.   

Abstract

From 2001 to 2012, arterial reconstruction was performed in 306 out of 497 limbs (62%) with critical limb ischemia. The reasons for non-vascularization include high operative risk (36%), extended necrosis or infection (20%), and technical issues (15%). Cumulative patency and limb salvage in collagen disease were significantly worse compared to arteriosclerosis obliterans. Cumulative limb salvage, amputation free survival (AFS), and major adverse limb event and perioperative death (MALE + POD) in patients with end-stage renal disease (ESRD) were significantly worse compared to patients without ESRD, but not significant with regards to graft patency. Our finding suggests that aggressive arterial reconstruction provides satisfactory long-term results in critical limb ischemia so long as case selection for revascularization is properly made. (This article is a translation of J Jpn Coll Angiol 2014; 54: 5-11.).

Entities:  

Keywords:  arterial reconstruction; arteriosclerosis obliterans; critical limb ischemia; peripheral arterial disease

Year:  2015        PMID: 26421066      PMCID: PMC4575329          DOI: 10.3400/avd.oa.15-00074

Source DB:  PubMed          Journal:  Ann Vasc Dis        ISSN: 1881-641X


  14 in total

1.  Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).

Authors:  L Norgren; W R Hiatt; J A Dormandy; M R Nehler; K A Harris; F G R Fowkes
Journal:  J Vasc Surg       Date:  2007-01       Impact factor: 4.268

2.  Use of a nondissection method in lower extremity revascularization: a report on our 12-year experience of autogenous vein bypass surgery.

Authors:  Y Takayama; A Takagi; O Sato; T Miyata; H Kimura; Y Sugawara; Y Tada
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

3.  Recommended standards for reports dealing with lower extremity ischemia: revised version.

Authors:  R B Rutherford; J D Baker; C Ernst; K W Johnston; J M Porter; S Ahn; D N Jones
Journal:  J Vasc Surg       Date:  1997-09       Impact factor: 4.268

4.  Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: Analysis of amputation free and overall survival by treatment received.

Authors:  Andrew W Bradbury; Donald J Adam; Jocelyn Bell; John F Forbes; F Gerry R Fowkes; Ian Gillespie; Charles Vaughan Ruckley; Gillian M Raab
Journal:  J Vasc Surg       Date:  2010-05       Impact factor: 4.268

5.  Unblinded pilot study of autologous transplantation of bone marrow mononuclear cells in patients with thromboangiitis obliterans.

Authors:  Koji Miyamoto; Kazuhiro Nishigami; Noritoshi Nagaya; Koichi Akutsu; Masaaki Chiku; Masataka Kamei; Toshihiro Soma; Shigeki Miyata; Masahiro Higashi; Ryoichi Tanaka; Takeshi Nakatani; Hiroshi Nonogi; Satoshi Takeshita
Journal:  Circulation       Date:  2006-12-04       Impact factor: 29.690

6.  Limb salvage after successful pedal bypass grafting is associated with improved long-term survival.

Authors:  M Kalra; P Gloviczki; T C Bower; J M Panneton; W S Harmsen; G D Jenkins; A W Stanson; B J Toomey; L G Canton
Journal:  J Vasc Surg       Date:  2001-01       Impact factor: 4.268

7.  Treatment of thromboangiitis obliterans (Buerger's disease) by intramuscular gene transfer of vascular endothelial growth factor: preliminary clinical results.

Authors:  J M Isner; I Baumgartner; G Rauh; R Schainfeld; R Blair; O Manor; S Razvi; J F Symes
Journal:  J Vasc Surg       Date:  1998-12       Impact factor: 4.268

8.  Therapeutic angiogenesis by controlled-release fibroblast growth factor in a patient with Churg-Strauss syndrome complicated by an intractable ischemic leg ulcer.

Authors:  Hidekazu Kawanaka; Gen Takagi; Masaaki Miyamoto; Shuhei Tara; Ikuyo Takagi; Hitoshi Takano; Masahiro Yasutake; Yasuhiko Tabata; Kyoichi Mizuno
Journal:  Am J Med Sci       Date:  2009-10       Impact factor: 2.378

9.  Failure of foot salvage in patients with end-stage renal disease after surgical revascularization.

Authors:  B L Johnson; M H Glickman; D F Bandyk; G E Esses
Journal:  J Vasc Surg       Date:  1995-09       Impact factor: 4.268

10.  Long-term outcome of therapeutic neovascularization using peripheral blood mononuclear cells for limb ischemia.

Authors:  Junji Moriya; Tohru Minamino; Kaoru Tateno; Naomi Shimizu; Yoichi Kuwabara; Yasunori Sato; Yasushi Saito; Issei Komuro
Journal:  Circ Cardiovasc Interv       Date:  2009-03-30       Impact factor: 6.546

View more
  7 in total

1.  The efficacy of a multidisciplinary team approach in critical limb ischemia.

Authors:  Hiroshi Suzuki; Atsuo Maeda; Hideyuki Maezawa; Tomoichiro Togo; Hitoshi Nemoto; Yoshiaki Kasai; Yoshinori Ito; Tokio Nakada; Hirohiko Sueki; Aya Mizukami; Mamiko Takayasu; Kenji Iwaku; Susumu Takeuchi; Hiroyuki Tanaka; Yoshitaka Iso
Journal:  Heart Vessels       Date:  2016-04-22       Impact factor: 2.037

2.  Neutrophil-to-lymphocyte ratio is effective prognostic indicator for post-amputation patients with critical limb ischemia.

Authors:  Qi Wang; Han Liu; Siqiao Sun; Zhihua Cheng; Yang Zhang; Xiwei Sun; Zhongying Wang; Shuai Wang
Journal:  Saudi Med J       Date:  2017-01       Impact factor: 1.484

3.  Distal Bypass to the Palmar Arch to Rescue Digital Ischemia Due to Peripheral Artery Disease.

Authors:  Tsukasa Nakamura; Shuji Nobori; Kiyokazu Akioka; Koji Masuda; Shumpei Harada; Masafumi Osaka; Takehisa Matsuyama; Norio Yoshimura; Hidetaka Ushigome
Journal:  Ann Vasc Dis       Date:  2018-09-25

4.  Review of Transmetatarsal Amputations in the Management of Peripheral Arterial Disease in an Asian Population.

Authors:  Ming Ngan Aloysius Tan; Zhiwen Joseph Lo; Soon Hong Lee; Rui Ming Teo; Wei Leong Glenn Tan; Sadhana Chandrasekar
Journal:  Ann Vasc Dis       Date:  2018-06-25

5.  Long-Term Outcomes of Acute Limb Ischemia: A Retrospective Analysis of 93 Consecutive Limbs.

Authors:  Michihisa Umetsu; Daijirou Akamatsu; Hitoshi Goto; Masato Ohara; Munetaka Hashimoto; Takuya Shimizu; Hirofumi Sugawara; Ken Tsuchida; Yoshitaro Yoshida; Yuta Tajima; Shunya Suzuki; Shinichiro Horii; Tetsuo Watanabe; Shigehito Miyagi; Michiaki Unno; Takashi Kamei
Journal:  Ann Vasc Dis       Date:  2019-09-25

6.  Prevalence, clinical characteristics, and predictors of peripheral arterial disease in hemodialysis patients: a cross-sectional study.

Authors:  Radislav R Ašćerić; Nada B Dimković; Goran Ž Trajković; Biljana S Ristić; Aleksandar N Janković; Petar S Durić; Nenad S Ilijevski
Journal:  BMC Nephrol       Date:  2019-07-26       Impact factor: 2.388

7.  Therapeutic angiogenesis using autologous adipose-derived regenerative cells in patients with critical limb ischaemia in Japan: a clinical pilot study.

Authors:  Takeshi Katagiri; Kazuhisa Kondo; Rei Shibata; Ryo Hayashida; Satoshi Shintani; Shukuro Yamaguchi; Yuuki Shimizu; Kazumasa Unno; Ryosuke Kikuchi; Akio Kodama; Keisuke Takanari; Yuzuru Kamei; Kimihiro Komori; Toyoaki Murohara
Journal:  Sci Rep       Date:  2020-09-29       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.